Abstract
Surgical robotic use has grown exponentially in spite of limited or uncertain benefits and large costs. In certain situations, adoption of robotic technology provides value to patients and society. In other cases, however, the robot provides little or no increase in surgical quality, with increased expense, and, therefore, does not add value to health care. The surgical robot is expensive to purchase, maintain and operate, and can contribute to increased consumerism in relation to surgical procedures, and increased reliance on the technology, thus driving future increases in health-care expenditure. Given the current need for budget constraints, the cost-effectiveness of specific procedures must be evaluated. The surgical robot should be used when cost-effective, but traditional open and laparoscopic techniques also need to be continually fostered.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Barbash, G. I. & Glied, S. A. New technology and health care costs--the case of robot-assisted surgery. N. Engl. J. Med. 363, 701–704 (2010).
Gandaglia, G. et al. Comparative effectiveness of robot-assisted and open radical prostatectomy in the postdissemination era. J. Clin. Oncol. 32, 1419–1426 (2014).
Parsons, J. K., Messer, K., Palazzi, K., Stroup, S. P. & Chang, D. Diffusion of surgical innovations, patient safety, and minimally invasive radical prostatectomy. JAMA Surg. 149, 845–851 (2014).
Close, A. et al. Comparative cost-effectiveness of robot-assisted and standard laparoscopic prostatectomy as alternatives to open radical prostatectomy for treatment of men with localised prostate cancer: a health technology assessment from the perspective of the UK National Health Service. Eur. Urol. 64, 361–369 (2013).
Nguyen, P. L. et al. Cost implications of the rapid adoption of newer technologies for treating prostate cancer. J. Clin. Oncol. 29, 1517–1524 (2011).
Malcolm, J. B. et al. Quality of life after open or robotic prostatectomy, cryoablation or brachytherapy for localized prostate cancer. J. Urol. 183, 1822–1828 (2010).
Badani, K. K., Kaul, S. & Menon, M. Evolution of robotic radical prostatectomy. Cancer 110, 1951–1958 (2007).
Patel, V. R., Tully, A. S., Holmes, R. & Lindsay, J. Robotic radical prostatectomy in the community setting--the learning curve and beyond: initial 200 cases. J. Urol. 174, 269–272 (2005).
Schroeck, F. R. et al. Satisfaction and regret after open retropubic or robot-assisted laparoscopic radical prostatectomy. Eur. Urol. 54, 785–793 (2008).
Burgess, S. V., Atug, F., Castle, E. P., Davis, R. & Thomas, R. Cost analysis of radical retropubic, perineal, and robotic prostatectomy. J. Endourol. 20, 827–830 (2006).
Jacobs, B. L. et al. Use of advanced treatment technologies among men at low risk of dying from prostate cancer. JAMA 309, 2587–2595 (2013).
Porter, M. E. A strategy for health care reform—toward a value-based system. N. Engl. J. Med. 361, 109–112 (2009).
Bolenz, C. et al. Cost comparison of robotic, laparoscopic, and open radical prostatectomy for prostate cancer. Eur. Urol. 57, 453–458 (2010).
Ahmed, K. et al. Assessing the cost effectiveness of robotics in urological surgery—a systematic review. BJU Int. 110, 1544–1556 (2012).
Yu, H. Y. et al. Hospital volume, utilization, costs and outcomes of robot-assisted laparoscopic radical prostatectomy. J. Urol. 187, 1632–1637 (2012).
Hyams, E. S. et al. Impact of robotic technique and surgical volume on the cost of radical prostatectomy. J. Endourol. 27, 298–303 (2013).
Alemozaffar, M. et al. Comparing costs of robotic, laparoscopic, and open partial nephrectomy. J. Endourol. 27, 560–565 (2013).
Smith, A. et al. Cost analysis of robotic versus open radical cystectomy for bladder cancer. J. Urol. 183, 505–509 (2010).
Patel, H. D. et al. Trends in renal surgery: robotic technology is associated with increased use of partial nephrectomy. J. Urol. 189, 1229–1235 (2013).
Altekruse, S. F. et al. SEER cancer statistics review, 1975–2007, National Cancer Institute. Bethesda, MD. Surveillance, Epidemiology, and End Results Program [online], (2010).
Alkhateeb, S. & Lawrentschuk, N. Consumerism and its impact on robotic-assisted radical prostatectomy. BJU Int. 108, 1874–1878 (2011).
United States General Accounting Office. FDA oversight of direct-to-consumer advertising has limitations. Report to congressional requesters GAO-03-177. General Accounting Office [online], (2002).
Scardino, P. T. Intoxicated by technology: are we keeping our eyes on the prize? Nat. Clin. Pract. Urol. 4, 231 (2007).
Eastham, J. A. Robotic-assisted prostatectomy: is there truth in advertising? Eur. Urol. 54, 720–722 (2008).
Wirth, M. P. & Hakenberg, O. W. Surgery and marketing: comparing different methods of radical prostatectomy. Eur. Urol. 55, 1031–1033 (2009).
Mirkin, J. N. et al. Direct-to-consumer internet promotion of robotic prostatectomy exhibits varying quality of information. Health Aff. (Millwood) 31, 760–769 (2012).
Miller, D. C., Hollingsworth, J. M., Hafez, K. S., Daignault, S. & Hollenbeck, B. K. Partial nephrectomy for small renal masses: an emerging quality of care concern? J. Urol. 175, 853–857 (2006).
Hollenbeck, B. K., Taub, D. A., Miller, D. C., Dunn, R. L. & Wei, J. T. National utilization trends of partial nephrectomy for renal cell carcinoma: a case of underutilization? Urology 67, 254–259 (2006).
McKiernan, J., Simmons, R., Katz, J. & Russo, P. Natural history of chronic renal insufficiency after partial and radical nephrectomy. Urology 59, 816–820 (2002).
Tan, H. J. et al. Long-term survival following partial vs radical nephrectomy among older patients with early-stage kidney cancer. JAMA 307, 1629–1635 (2012).
Shinohara, N. et al. Impact of nephron-sparing surgery on quality of life in patients with localized renal cell carcinoma. Eur. Urol. 39, 114–119 (2001).
Rabbani, F., Herr, H. W., Almahmeed, T. & Russo, P. Temporal change in risk of metachronous contralateral renal cell carcinoma: influence of tumor characteristics and demographic factors. J. Clin. Oncol. 20, 2370–2375 (2002).
Clark, P. E. et al. Quality of life and psychological adaptation after surgical treatment for localized renal cell carcinoma: impact of the amount of remaining renal tissue. Urology 57, 252–256 (2001).
Miller, D. C. et al. Diffusion of surgical innovation among patients with kidney cancer. Cancer 112, 1708–1717 (2008).
Ficarra, V. et al. Retropubic, laparoscopic, and robot-assisted radical prostatectomy: a systematic review and cumulative analysis of comparative studies. Eur. Urol. 55, 1037–1063 (2009).
Berryhill, R. Jr et al. Robotic prostatectomy: a review of outcomes compared with laparoscopic and open approaches. Urology 72, 15–23 (2008).
Lowrance, W. T. et al. Comparative effectiveness of prostate cancer surgical treatments: a population based analysis of postoperative outcomes. J. Urol. 183, 1366–1372 (2010).
Yu, H. Y., Hevelone, N. D., Lipsitz, S. R., Kowalczyk, K. J. & Hu, J. C. Use, costs and comparative effectiveness of robotic assisted, laparoscopic and open urological surgery. J. Urol. 187, 1392–1398 (2012).
Anderson, J. E., Chang, D. C., Parsons, J. K. & Talamini, M. A. The first national examination of outcomes and trends in robotic surgery in the United States. J. Am. Coll. Surg. 215, 107–114 (2012).
Mirheydar, H. S. & Parsons, J. K. Diffusion of robotics into clinical practice in the United States: process, patient safety, learning curves, and the public health. World J. Urol. 31, 455–461 (2013).
Hu, J. C. et al. Comparative effectiveness of minimally invasive vs open radical prostatectomy. JAMA 302, 1557–1564 (2009).
Novara, G. et al. Systematic review and meta-analysis of studies reporting oncologic outcome after robot-assisted radical prostatectomy. Eur. Urol. 62, 382–404 (2012).
Picozzi, S. C., Ricci, C. & Carmignani, L. Re: Giacomo Novara, Vincenzo Ficarra, Simone Mocellin, et al. Systematic review and meta-analysis of studies reporting oncologic outcome after robot-assisted radical prostatectomy. Eur Urol 2012;62:382–404. Eur. Urol. 63, e27–e28 (2013).
Williams, S. B. et al. Radical retropubic prostatectomy and robotic-assisted laparoscopic prostatectomy: likelihood of positive surgical margin(s). Urology 76, 1097–1101 (2010).
Diaz, M. et al. Oncologic outcomes at 10 years following robotic radical prostatectomy. Eur. Urol. http:dx.doi.org/10.1016/j.eururo.2014.06.025.
Tasci, A. I. et al. Oncologic results, functional outcomes, and complication rates of robotic-assisted radical prostatectomy: multicenter experience in Turkey including 1,499 patients. World J. Urol. http:dx.doi.org/10.1007/s00345-014-1393-3.
Pierorazio, P. M. et al. Trends in immediate perioperative morbidity and delay in discharge after open and minimally invasive radical prostatectomy (RP): a 20-year institutional experience. BJU Int. 112, 45–53 (2013).
Park, J. et al. Comparison of oncological outcomes between retropubic radical prostatectomy and robot-assisted radical prostatectomy: an analysis stratified by surgical experience. World J. Urol. 32, 193–199 (2014).
Deane, L. A. et al. Robotic versus standard laparoscopic partial/wedge nephrectomy: a comparison of intraoperative and perioperative results from a single institution. J. Endourol. 22, 947–952 (2008).
Link, R. E. et al. Exploring the learning curve, pathological outcomes and perioperative morbidity of laparoscopic partial nephrectomy performed for renal mass. J. Urol. 173, 1690–1694 (2005).
Benway, B. M. et al. Robot assisted partial nephrectomy versus laparoscopic partial nephrectomy for renal tumors: a multi-institutional analysis of perioperative outcomes. J. Urol. 182, 866–872 (2009).
Gill, I. S., Kamoi, K., Aron, M. & Desai, M. M. 800 laparoscopic partial nephrectomies: a single surgeon series. J. Urol. 183, 34–41 (2010).
Huang, W. C., Elkin, E. B., Levey, A. S., Jang, T. L. & Russo, P. Partial nephrectomy versus radical nephrectomy in patients with small renal tumors--is there a difference in mortality and cardiovascular outcomes? J. Urol. 181, 55–61 (2009).
Thompson, R. H. et al. Radical nephrectomy for pT1a renal masses may be associated with decreased overall survival compared with partial nephrectomy. J. Urol. 179, 468–471 (2008).
Van Poppel, H. et al. A prospective, randomised EORTC intergroup phase 3 study comparing the oncologic outcome of elective nephron-sparing surgery and radical nephrectomy for low-stage renal cell carcinoma. Eur. Urol. 59, 543–552 (2011).
Lau, W. K., Blute, M. L., Weaver, A. L., Torres, V. E. & Zincke, H. Matched comparison of radical nephrectomy vs nephron-sparing surgery in patients with unilateral renal cell carcinoma and a normal contralateral kidney. Mayo Clin. Proc. 75, 1236–1242 (2000).
Gill, I. S. et al. Comparative analysis of laparoscopic versus open partial nephrectomy for renal tumors in 200 patients. J. Urol. 170, 64–68 (2003).
Gill, I. S. et al. Comparison of 1,800 laparoscopic and open partial nephrectomies for single renal tumors. J. Urol. 178, 41–46 (2007).
Lane, B. R., Campbell, S. C. & Gill, I. S. 10-year oncologic outcomes after laparoscopic and open partial nephrectomy. J. Urol. 190, 44–49 (2013).
Mir, S. A., Cadeddu, J. A., Sleeper, J. P. & Lotan, Y. Cost comparison of robotic, laparoscopic, and open partial nephrectomy. J. Endourol. 25, 447–453 (2011).
Aron, M. et al. Robotic and laparoscopic partial nephrectomy: a matched-pair comparison from a high-volume centre. BJU Int. 102, 86–92 (2008).
Aboumarzouk, O. M. et al. Robotic versus laparoscopic partial nephrectomy: a systematic review and meta-analysis. Eur. Urol. 62, 1023–1033 (2012).
Parekh, D. J., Messer, J., Fitzgerald, J., Ercole, B. & Svatek, R. Perioperative outcomes and oncologic efficacy from a pilot prospective randomized clinical trial of open versus robotic assisted radical cystectomy. J. Urol. 189, 474–479 (2013).
Wang, G. J., Barocas, D. A., Raman, J. D. & Scherr, D. S. Robotic vs open radical cystectomy: prospective comparison of perioperative outcomes and pathological measures of early oncological efficacy. BJU Int. 101, 89–93 (2008).
Nix, J. et al. Prospective randomized controlled trial of robotic versus open radical cystectomy for bladder cancer: perioperative and pathologic results. Eur. Urol. 57, 196–201 (2010).
Cohen, S. A. et al. Minimally invasive cystectomy is associated with improved perioperative patient safety outcomes compared with open cystectomy in a national cohort. Urology 84, 314–319 (2014).
Bochner, B. H., Sjoberg, D. D. & Laudone, V. P. A randomized trial of robot-assisted laparoscopic radical cystectomy. N. Engl. J. Med. 371, 389–390 (2014).
Gan, C. et al. A pilot prospective single-centre 3-arm randomised controlled trial of open, robotic and laparoscopic (coral) radical cystectomy for bladder cancer [abstract 1624]. J. Urol. 189, e667–e668 (2013).
Challacombe, B. J. et al. The role of laparoscopic and robotic cystectomy in the management of muscle-invasive bladder cancer with special emphasis on cancer control and complications. Eur. Urol. 60, 767–775 (2011).
Simonato, A. & Ennas, M. Re: Ben J. Challacombe, Bernard H. Bochner, Prokar Dasgupta. et al. The role of laparoscopic and robotic cystectomy in the management of muscle-invasive bladder cancer with special emphasis on cancer control and complications. Eur Urol 2011;60:767-75. Eur. Urol. 61, e29 (2012).
Lowrance, W. T. et al. Costs of medical care after open or minimally invasive prostate cancer surgery: a population-based analysis. Cancer 118, 3079–3086 (2012).
Kim, S. P. et al. Hospitalization costs for radical prostatectomy attributable to robotic surgery. Eur. Urol. 64, 11–16 (2013).
Lee, R. et al. The economics of robotic cystectomy: cost comparison of open versus robotic cystectomy. BJU Int. 108, 1886–1892 (2011).
Martin, A. D., Nunez, R. N. & Castle, E. P. Robot-assisted radical cystectomy versus open radical cystectomy: a complete cost analysis. Urology 77, 621–625 (2011).
Author information
Authors and Affiliations
Contributions
All authors contributed to researching data for the article, discussing content and writing the article, as well as reviewing and editing the manuscript before submission.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
Kaye, D., Mullins, J., Carter, H. et al. Robotic surgery in urological oncology: patient care or market share?. Nat Rev Urol 12, 55–60 (2015). https://doi.org/10.1038/nrurol.2014.339
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrurol.2014.339
This article is cited by
-
A multimodal virtual vision platform as a next-generation vision system for a surgical robot
Medical & Biological Engineering & Computing (2024)
-
Market potentials of robotic systems in medical science: analysis of the Avatera robotic system
World Journal of Urology (2022)
-
Robot-assisted simple prostatectomy versus open simple prostatectomy: a single-center comparison
World Journal of Urology (2021)
-
Considering the role of radical prostatectomy in 21st century prostate cancer care
Nature Reviews Urology (2020)
-
Transoral robotic surgery for the base of tongue squamous cell carcinoma: a preliminary comparison between da Vinci Xi and Si
Journal of Robotic Surgery (2018)